Myraquat

Foundation date

14/04/2020

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Myraquat develops therapeutic compounds acting as membrane modulators to control pathogenic microorganisms.

Upcoming events

Latest news

  • Cerba Research & Teddy Lab sign Memorandum of Understanding on entering into a discussion for Joint Venture

    7 hours ago

  • Novalis Biotech invests in Rarity Bioscience's ultra sensitive genomics technology

    1 day ago

  • Fat creates an ideal environment for metastatic breast tumors

    1 day ago